358 related articles for article (PubMed ID: 33425259)
1. Deimmunization of protein therapeutics - Recent advances in experimental and computational epitope prediction and deletion.
Zinsli LV; Stierlin N; Loessner MJ; Schmelcher M
Comput Struct Biotechnol J; 2021; 19():315-329. PubMed ID: 33425259
[TBL] [Abstract][Full Text] [Related]
2. T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation.
Jawa V; Cousens LP; Awwad M; Wakshull E; Kropshofer H; De Groot AS
Clin Immunol; 2013 Dec; 149(3):534-55. PubMed ID: 24263283
[TBL] [Abstract][Full Text] [Related]
3. Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads.
Salvat RS; Choi Y; Bishop A; Bailey-Kellogg C; Griswold KE
Biotechnol Bioeng; 2015 Jul; 112(7):1306-18. PubMed ID: 25655032
[TBL] [Abstract][Full Text] [Related]
4. T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics.
Sun R; Qian MG; Zhang X
MAbs; 2024; 16(1):2324836. PubMed ID: 38512798
[TBL] [Abstract][Full Text] [Related]
5. Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody.
Xue L; Hickling T; Song R; Nowak J; Rup B
Clin Exp Immunol; 2016 Jan; 183(1):102-13. PubMed ID: 26400440
[TBL] [Abstract][Full Text] [Related]
6. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
Hafner AM; Corthésy B; Merkle HP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
[TBL] [Abstract][Full Text] [Related]
7. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
[TBL] [Abstract][Full Text] [Related]
8. EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining Function.
Choi Y; Verma D; Griswold KE; Bailey-Kellogg C
Methods Mol Biol; 2017; 1529():375-398. PubMed ID: 27914063
[TBL] [Abstract][Full Text] [Related]
9. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
[TBL] [Abstract][Full Text] [Related]
10. An innovative method for characterizing neutralizing antibodies against antibody-derived therapeutics.
Coddens A; Snoeck V; Bontinck L; Buyse MA; Pine SO
J Immunol Methods; 2020 Dec; 487():112896. PubMed ID: 33065122
[TBL] [Abstract][Full Text] [Related]
11. Full-length recombinant antibodies from
Rashid MH
MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
[TBL] [Abstract][Full Text] [Related]
12. INeo-Epp: A Novel T-Cell HLA Class-I Immunogenicity or Neoantigenic Epitope Prediction Method Based on Sequence-Related Amino Acid Features.
Wang G; Wan H; Jian X; Li Y; Ouyang J; Tan X; Zhao Y; Lin Y; Xie L
Biomed Res Int; 2020; 2020():5798356. PubMed ID: 32626747
[TBL] [Abstract][Full Text] [Related]
13. Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity.
Dhanda SK; Grifoni A; Pham J; Vaughan K; Sidney J; Peters B; Sette A
Immunology; 2018 Jan; 153(1):118-132. PubMed ID: 28833085
[TBL] [Abstract][Full Text] [Related]
14. Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics.
Nagata S; Pastan I
Adv Drug Deliv Rev; 2009 Sep; 61(11):977-85. PubMed ID: 19679153
[TBL] [Abstract][Full Text] [Related]
15. Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases.
Nakamura Y; Moi ML; Shiina T; Shin-I T; Suzuki R
Viruses; 2023 May; 15(5):. PubMed ID: 37243272
[TBL] [Abstract][Full Text] [Related]
16. Functional Deimmunization of Interferon Beta-1b by Identifying and Silencing Human T Cells Epitopes.
Moradi Hasan-Abad A; Adabi E; Sadroddiny E; Khorramizadeh MR; Mazlomi MA; Mehravar S; Kardar GA
Iran J Allergy Asthma Immunol; 2019 Aug; 18(4):427-440. PubMed ID: 31522451
[TBL] [Abstract][Full Text] [Related]
17. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
[TBL] [Abstract][Full Text] [Related]
18. An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production.
Ziegler A; Olzhausen J; Hamza E; Stojiljkovic A; Stoffel MH; Garbani M; Rhyner C; Marti E
Vet Immunol Immunopathol; 2022 Jan; 243():110351. PubMed ID: 34800874
[TBL] [Abstract][Full Text] [Related]
19. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
Nosrati M; Mohabatkar H; Behbahani M
Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.
Cantor JR; Yoo TH; Dixit A; Iverson BL; Forsthuber TG; Georgiou G
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1272-7. PubMed ID: 21209329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
